$7.370
-0.361 (-4.90%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Akari Therapeutics PLC (AKTX) Moving Averages Convergence Divergence (MACD) indicator is -0.28, suggesting AKTX is Strong sell.
Akari Therapeutics PLC (AKTX) 20-Day simple moving average is 8.35, while Akari Therapeutics PLC (AKTX) share price is $—, making it Sell.
Akari Therapeutics PLC (AKTX) 60-Day simple moving average is 9.05, while Akari Therapeutics PLC (AKTX) share price is $—, making it Sell.
Technical Analysis for AKTX
AI Technical AKTXAs of 2026-11-07, the technical board for Akari Therapeutics PLC (AKTX) reads strong sell: 1 indicators are flashing buy, 9 are indicating sell, and 3 are neutral. Price at $7.37 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 43.316, MACD stands at -0.283 (Sell), Stochastic %K stands at 27.48, Stochastic %D stands at 37.414 and CCI stands at -121.05 (Buy).
AKTX trades below the 60-day SMA (9.05) and below the 200-day SMA (8.99). Immediate resistance sits at Classic R1 9.60, then R2 10.99. Support sits at Classic S1 7.04, then S2 5.88.
Akari Therapeutics PLC (AKTX) Support & Resistance Level
Akari Therapeutics PLC (AKTX) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 43.316 |
| STOCHk_14_3_3 | 27.480 |
| STOCHd_14_3_3 | 37.414 |
| CCI_20 | -121.050 |
| AO_5_34 | -0.552 |
| MOM_10 | -0.855 |
| MACD_12_26_9 | -0.283 |
Akari Therapeutics PLC (AKTX) Relative Strength Index (RSI_14) is 43.316, creating a Neutral signal.
Akari Therapeutics PLC (AKTX) Stochastic %K is 27.480, creating a Neutral signal.
Akari Therapeutics PLC (AKTX) Stochastic %D is 37.414, creating a Neutral signal.
Akari Therapeutics PLC (AKTX) CCI_20 is -121.050, creating a Buy signal.
Akari Therapeutics PLC (AKTX) Awesome Oscillator (AO) is -0.552, creating a Sell signal.
Akari Therapeutics PLC (AKTX) Momentum (MOM) is -0.855, creating a Sell signal.
Akari Therapeutics PLC (AKTX) Moving Average Convergence Divergence (MACD) is -0.283, creating a Sell signal.
Akari Therapeutics PLC (AKTX) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 8.080 | Sell |
| MA_10 | 8.205 | Sell |
| MA_20 | 8.353 | Sell |
| MA_60 | 9.054 | Sell |
| MA_200 | 8.994 | Sell |
| MA_250 | 10.052 | Sell |
Akari Therapeutics PLC (AKTX) 5-Day simple moving average is 8.080, while Akari Therapeutics PLC (AKTX) share price is $, making it a Sell.
Akari Therapeutics PLC (AKTX) 10-Day simple moving average is 8.205, while Akari Therapeutics PLC (AKTX) share price is $, making it a Sell.
Akari Therapeutics PLC (AKTX) 20-Day simple moving average is 8.353, while Akari Therapeutics PLC (AKTX) share price is $, making it a Sell.
Akari Therapeutics PLC (AKTX) 60-Day simple moving average is 9.054, while Akari Therapeutics PLC (AKTX) share price is $, making it a Sell.
Akari Therapeutics PLC (AKTX) 200-Day simple moving average is 8.994, while Akari Therapeutics PLC (AKTX) share price is $, making it a Sell.
Akari Therapeutics PLC (AKTX) 250-Day simple moving average is 10.052, while Akari Therapeutics PLC (AKTX) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.